BRAF V600E MUTATION AND AMPHIREGULIN (AR) IMMUNOHISTOCHEMICAL EXPRESSION IN THE PREDICTION OFBENEFIT FROM CETUXIMAB PLUS IRINOTECAN IN KRAS WILDTYPEMETASTATIC COLORECTAL CANCER (MCRC) PATIENTS

Autor:	Cremolini, C, Loupakis, F, Perrone, G, Ruzzo, Annamaria, Rulli, E, Garavaglia, D, Bencardino, K, Fornaro, L, Vincenzi, B, Stasi, I, Masi, G, Santini, D, Vasile, E, Salvatore, L, Baldi, Gg, Spoto, C, Tonini, G, Floriani, I, Graziano, F, Falcone, A.
Jazyk:	angličtina
Rok vydání:	2009
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3656::7ff5166dc5bea2421f6a3e9b99f327c7 https://hdl.handle.net/11576/2303296 Zobrazit plný text záznamu